(Q47946203)

7 February 2018

title

Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. (English)

1 reference

7 February 2018

0 references

Linda L Carpenter

1

1 reference

7 February 2018

George R Heninger

2

1 reference

7 February 2018

Robert T Malison

3

1 reference

7 February 2018

Audrey R Tyrka

4

1 reference

7 February 2018

Lawrence H Price

5

1 reference

7 February 2018

publication date

1 April 2004

1 reference

7 February 2018

Journal of Affective Disorders

published in

1 reference

7 February 2018

volume

79

1 reference

7 February 2018

issue

1-3

1 reference

7 February 2018

page(s)

285-289

1 reference

7 February 2018

Blood levels of cytokines in elderly patients with major depressive disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Depression, stress and immunological activation: the role of cytokines in depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Cytokines and the nervous system. I: Expression and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Cytokines and the brain: implications for clinical psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Cytokine production and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Changes in the immune system in depression and dementia: causal or co-incidental effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Immune–inflammatory markers in patients with seasonal affective disorder: effects of light therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Cerebrospinal cytokine levels in patients with acute depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Immunoendocrine aspects of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Mood disorders associated with interferon treatment: theoretical and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Stress and depression: is neuroimmunology the missing link?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Indicators of immune activation in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900460-3

7 January 2021

10.1016/S0165-0327(02)00460-3

Identifiers

DOI

1 reference

7 February 2018

release_teooxsgepjaazowenxokhnuyzi

Fatcat ID

0 references

PubMed ID

15023509

1 reference

7 February 2018